Results 181 to 190 of about 93,713 (304)
Abstract Background Type 1 diabetes (T1D) follows a staged autoimmune natural history, yet most evidence describing progression derives from highly selected, genetically at‐risk cohorts. Methods Using the TriNetX Network, we identified eight cohorts of autoantibody‐positive individuals without prior T1D. Four cohorts had preserved glycaemia (HbA1c ≤5.6%
Matthew Anson +7 more
wiley +1 more source
Endoscopic diagnosis and treatment of colon cancer: current evidence and future directions. [PDF]
Gong H, Li H, Zheng Z, Zhu H, Zhang Y.
europepmc +1 more source
ABSTRACT Background Individually, sodium–glucose co‐transporter‐2 inhibitors (SGLT2i) and glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) have been shown to reduce major kidney and cardiovascular events in patients with chronic kidney disease (CKD). However, evidence supporting combined GLP‐1RA and SGLT2i therapy in this population remains limited.
Hussain Salim +9 more
wiley +1 more source
Cold Resection for Superficial Non-Ampullary Duodenal Epithelial Tumors: Current Evidence and Clinical Perspectives. [PDF]
Mikuriya Y +3 more
europepmc +1 more source
Dapagliflozin Alters Plasma Metabolome in Patients With Type 1 Diabetes During Ketosis
ABSTRACT Aims Use of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in patients with type 1 diabetes (T1D) is limited by increased risk of ketoacidosis. We aimed to determine metabolic pathways affected by SGLT2i treatment in adults with T1D during ketosis induced by insulin withdrawal.
Rosa Yang +6 more
wiley +1 more source
Abstract Many organizations and their stakeholders are facing major technological, societal, and geopolitical shifts, making it increasingly necessary to jointly shape desirable futures. This Perspective paper builds on Romme's research program that seeks to re‐introduce a problem‐solving (i.e., engineering) mindset in management research.
A. Georges L. Romme +3 more
wiley +1 more source
Abstract Objectives/Background The introduction of calcitonin gene‐related peptide antagonists has transformed migraine care. Zavegepant, a third‐generation intranasal gepant, offers a nonoral treatment option for acute migraine. Although clinical trials support its efficacy and safety, real‐world data are limited.
Eric Dunn +5 more
wiley +1 more source
Endoscopic salvage of a complex post-endoscopic mucosal resection duodenal perforation. [PDF]
Paspatis GA +6 more
europepmc +1 more source
Abstract Objective This study aimed to evaluate whether care in a subspecialty headache center, compared with a general neurology clinic, was associated with lower 90‐day unplanned healthcare utilization (HCU) in patients with migraine and to identify patient‐level factors associated with higher unplanned HCU. Background Migraine is a common, disabling
Megan Trenz +7 more
wiley +1 more source
Development and Internal Validation of an Electronic Medical Record-Based Machine Learning Model for Frailty Prediction in Hospitalized Patients: Retrospective Cohort Study. [PDF]
Laurea Szabo GC +5 more
europepmc +1 more source

